Skip to Main Content

Analysis: most cited cardiovascular medicine research, summer 2023

September 04, 2023
by Elisabeth Reitman

There’s no shortage of research coauthored by faculty in the Section of Cardiovascular Medicine. View the most cited, read, and discussed research published over the summer.

Highly Cited Articles

Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020

Authors Lovedeep S. Dhingra, Arya Aminorroaya, Evangelos K. Oikonomou, Arash Aghajani Nargesi, Francis Perry Wilson, Harlan M. Krumholz, Rohan Khera

In this cross-sectional study based on a representative sample of 9,303 U.S. adults in 2019 and 2020, less than a quarter with established cardiovascular disease reported using wearable devices compared with 29% of the general population.

Acetate controls endothelial-to-mesenchymal transition

Authors Xiaolong Zhu, Yunyun Wang, Ioana Soaita, Heon-Woo Lee, Hosung Bae, Nabil Boutagy, Anna Bostwick, Rong-Mo Zhang, Caitlyn Bowman, Yanying Xu, Sophie Trefely, Yu Chen, Lingfeng Qin, William Sessa, George Tellides, Cholsoon Jang, Nathaniel W. Snyder, Luyang Yu, Zoltan Arany, Michael Simons

This study revealed the metabolic basis underlying vascular disease and insights for reversing once incurable diseases.

Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial

Authors Stephen J. Greene, Eric J. Velazquez, Kevin J. Anstrom, Robert M. Clare, Tracy A. DeWald, Mitchell A. Psotka, Andrew P. Ambrosy, Gerin R. Stevens, John J. Rommel, Tamas Alexy, Fassil Ketema, Dong-Yun Kim, Patrice Desvigne-Nickens, Bertram Pitt, Eric L. Eisenstein, Robert J. Mentz

Researchers from the TRANSFORM-HF trial found no significant difference between two loop diuretic agents — torsemide and furosemide — on symptoms and quality of life in patients with heart failure.

Submitted by Elisabeth Reitman on August 22, 2023